Cardinal Health

426 articles with Cardinal Health

• Cardinal Health Foundation Supports New Initiatives at the Ohio Hospital Association to Spread Best Practices in Opioid Prescribing

  1/7/2019

  Partnership builds on Cardinal Health's Opioid Action Program and Generation Rx

• Cardinal Health Elects J. Michael Losh to its Board of Directors

  12/7/2018

  Cardinal Health today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee.

• Pharmaceutical Industry Packaging Serialization Lagging as DSCSA Enforcement Deadline Looms

  10/18/2018

  Assessments by AmerisourceBergen, Cardinal Health, and McKesson Pharmaceutical Shows Nearly 80 Percent of Suppliers' Packages Do Not Meet Requirements

• Cardinal Health Welcomes Victor Crawford as CEO of Pharmaceutical Segment

  10/15/2018

  Cardinal Health (NYSE: CAH) today announced that Victor Crawford will be joining the company as its next CEO of the Pharmaceutical Segment.

• Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2019 on November 8

  10/15/2018

  Cardinal Health plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange.

• Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging

  10/3/2018

  Telix Pharmaceuticals (US) Inc. today announced that it has entered into a distribution agreement with Cardinal Health (NYSE:CAH).

• Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari™ (L-glutamine oral powder)

  9/19/2018

  Company Signs Fourth Major Distribution Agreement this Year

• 

  In Negotiations of 1,000 Opioid Lawsuits, Purdue Pharma Offers Free Opioid Therapy

  9/12/2018

  Purdue Pharma, best known for being the manufacturer of opioid drug OxyContin, is offering free doses of a treatment for opioid abuse as part of negotiations in more than 1,000 lawsuits.

• Cardinal Health Board of Directors Approves Quarterly Dividend of $0.4763 Per Share

  8/8/2018

  The Cardinal Health (NYSE: CAH) board of directors approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to shareholders of record at the close of business on October 1, 2018.

• Cardinal Health Reports Fourth-quarter and Year-end Results for Fiscal Year 2018

  8/6/2018

  Fourth-quarter revenue increased 7 percent to $35 billion; full-year revenue increased 5 percent to $137 billion

• Cardinal Health and Clayton, Dubilier & Rice Announce Partnership to Accelerate Growth of naviHealth

  6/13/2018

  Investment Accelerates naviHealth's Growing Market Position in Post-Acute Care Management

• FDA Advisory Committee Votes in Favor of Cardinal Health's INCRAFT® AAA Stent Graft System for the Endovascular Treatment of Infrarenal Abdominal Aortic Aneurysms

  6/12/2018

  Cardinal Health announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has provided a favorable recommendation on the premarket approval application for INCRAFT® AAA Stent Graft System (INCRAFT).

• 

  A Look at the Top 10 Medical Device Companies in 2018

  6/12/2018

  The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.

• Oncologists See Opportunities, Challenges with Emergence of Precision Medicine

  5/31/2018

  While nearly four in 10 oncologists view precision medicine as a potential game-changer, most (57 percent) say it's too soon to predict its long-term impact, according to new research from Cardinal Health Specialty Solutions.

• 

  Opioid Distributors on Congressional Hot Seat Over Addiction Crisis

  5/9/2018

  Sitting before a Congressional panel Tuesday the heads of pharmaceutical distributing companies said their mea culpas over not doing more to limit the flow of prescription opioids to certain parts of the country.

• Cardinal Health Reports Third-quarter Results for Fiscal Year 2018

  5/3/2018

  Cardinal Health (NYSE:CAH) today reported third-quarter fiscal year 2018 revenue of $33.6 billion, an increase of 6 percent.

• Cardinal Health urEssential Award Recognizes Laboratory Professor's Distinguished Career

  5/1/2018

  Cardinal Health named Dr. Mary Ann McLane the 2018 recipient of the Cardinal Health™ urEssential Award

• Cardinal Health Donates 16,000 Drug Disposal Envelopes to the National Community Pharmacists Association Foundation

  4/19/2018

  Donation will help consumers dispose of unused prescription medications safely and securely

• Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2018 on May 3

  4/3/2018

  Cardinal Health plans to release third-quarter financial results for its fiscal year 2018 on May 3 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.

• Cardinal Health Highlights Commitment To Gender Equity As Part Of Women's History Month Celebrations

  3/20/2018

  With conversations around gender equity in the workplace continuing across the country, Cardinal Health emphasized the company's ongoing commitment to promoting and supporting the advancement of women in the workplace.